UK markets closed
  • FTSE 100

    6,695.07
    -20.35 (-0.30%)
     
  • FTSE 250

    20,596.91
    -196.81 (-0.95%)
     
  • AIM

    1,195.31
    -2.78 (-0.23%)
     
  • GBP/EUR

    1.1236
    -0.0045 (-0.40%)
     
  • GBP/USD

    1.3685
    -0.0046 (-0.33%)
     
  • BTC-GBP

    23,239.29
    +0.54 (+0.00%)
     
  • CMC Crypto 200

    651.44
    +41.45 (+6.79%)
     
  • S&P 500

    3,841.47
    -11.60 (-0.30%)
     
  • DOW

    30,996.98
    -179.03 (-0.57%)
     
  • CRUDE OIL

    51.98
    -1.15 (-2.16%)
     
  • GOLD FUTURES

    1,855.50
    -10.40 (-0.56%)
     
  • NIKKEI 225

    28,631.45
    -125.41 (-0.44%)
     
  • HANG SENG

    29,447.85
    -479.91 (-1.60%)
     
  • DAX

    13,873.97
    -32.70 (-0.24%)
     
  • CAC 40

    5,559.57
    -31.22 (-0.56%)
     

DNA’s financial information and Annual General Meeting in 2021

DNA Oyj
·1-min read

DNA PLC STOCK EXCHANGE RELEASE 17 December 2020, 10:00 am EET

In 2021, DNA will publish its financial statements, semi-annual report and business reviews sent as press releases as follows:

  • 2 February 2021: Financial statements bulletin for 2020

  • 4 May 2021: January-March 2021 business review as press release

  • 20 July 2021: Half year (January-June) 2021 financial report

  • 28 October 2021: January-September 2021 business review as press release

DNA’s electronic annual report, which contains the complete Financial Statements 2020, will be published at the latest during the week starting from 1 March 2021 (week 9/2021).

DNA's Annual General Meeting is planned to be held on 26 March 2021.

Further information:
Timo Karppinen, CFO, DNA Plc, tel. +358 (0)44 044 5007, timo.karppinen@dna.fi
DNA Corporate Communications, tel. +358 44 044 8000, communications@dna.fi